GNH USA

Europe — EMA

Ondansetron Kabi (Ondansetron Hydrochloride Dihydrate)

GNH USA supplies Ondansetron Kabi (Ondansetron), a serotonin 5‑HT3 receptor antagonist for preventing chemotherapy, radiotherapy and postoperative nausea

Ondansetron Hydrochloride Dihydrate

Request sourcing

1
Pack/s

What is Ondansetron Hydrochloride Dihydrate?

Ondansetron, the active ingredient in Ondansetron Kabi, is a serotonin 5-HT3 receptor antagonist presented as an injectable solution for intravenous use. It prevents and treats nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative settings in patients. GNH USA supplies Ondansetron Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Ondansetron Hydrochloride Dihydrate used for?

Ondansetron Kabi acts on the serotonergic pathway to control emesis. - Chemotherapy‑induced nausea and vomiting: prevents and reduces nausea and vomiting in patients receiving cytotoxic chemotherapy. - Radiotherapy‑induced nausea and vomiting: controls nausea and vomiting that occur during or after radiation treatment. - Postoperative nausea and vomiting: reduces the incidence of nausea and vomiting following surgical procedures.

What are the side effects of Ondansetron Hydrochloride Dihydrate?

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: decreased bowel motility. - Dizziness: transient light‑headedness. - Fatigue: general tiredness. - Injection site reactions: erythema or discomfort. - Diarrhea: loose stools.

Serious or Rare Side Effects: - QT interval prolongation: may lead to cardiac arrhythmias. - Severe hypersensitivity: anaphylaxis or angioedema. - Serotonin syndrome: when combined with other serotonergic agents. - Severe hypotension: sudden drop in blood pressure. - Cardiac arrhythmia: ventricular tachycardia or fibrillation.

What precautions apply to Ondansetron Hydrochloride Dihydrate?

Before using Ondansetron Kabi, consider the following precautions: - Cardiac risk assessment: monitor QT interval in patients with known prolongation or electrolyte disturbances. - Hypersensitivity: avoid in individuals with known allergy to ondansetron or other 5‑HT3 antagonists. - Hepatic impairment: dose adjustment may be required in patients with severe liver dysfunction. - Pregnancy counseling: discuss potential risks with obstetrician; use only if benefit outweighs risk. - Electrolyte balance: correct hypokalemia or hypomagnesemia to reduce QT‑prolongation risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Ondansetron Hydrochloride Dihydrate interact with?

Ondansetron Kabi may interact with several medications. Major Interactions (Avoid): - Apomorphine: concurrent use can cause severe hypotension and loss of consciousness. - Other QT‑prolonging agents (e.g., quinidine, haloperidol, sotalol): increase risk of cardiac arrhythmias. Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise ondansetron plasma concentrations. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce therapeutic effect. - Serotonergic drugs (e.g., tramadol, SSRIs): monitor for signs of serotonin syndrome.

Frequently asked questions

What is Ondansetron Kabi used for?+
Ondansetron Kabi is an intravenous antiemetic indicated to prevent and treat nausea and vomiting that occur as a result of chemotherapy, radiotherapy, or after surgical procedures. It is employed in adult and pediatric patients where rapid control of emesis is required, helping improve comfort and adherence to cancer or surgical treatment protocols.
How does ondansetron work?+
Ondansetron works by selectively blocking serotonin type 3 (5‑HT3) receptors located in the central nervous system and the gastrointestinal tract. This antagonism prevents serotonin‑mediated activation of the chemoreceptor trigger zone and vagal afferent pathways, thereby reducing the neural signals that provoke nausea and vomiting.
What is the usual dose of Ondansetron Kabi?+
The dose of Ondansetron Kabi is determined by the prescribing clinician based on the specific indication, patient weight, renal and hepatic function, and the treatment protocol being followed. Healthcare professionals adjust the regimen to achieve optimal antiemetic control while considering individual patient factors.
Is Ondansetron Kabi safe in pregnancy and breastfeeding?+
Ondansetron Kabi is classified as Pregnancy Category B, indicating that animal studies have not shown risk but adequate human data are lacking. It should be used during pregnancy only if the potential benefit justifies the potential risk. Small amounts are excreted in breast milk; therefore, caution is advised while breastfeeding and a risk‑benefit assessment should be performed.
How do I order Ondansetron Kabi from GNH USA?+
To order Ondansetron Kabi, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and the necessary import documentation.
How does Ondansetron Kabi compare with other antiemetic drugs?+
Ondansetron Kabi belongs to the 5‑HT3 antagonist class and offers rapid intravenous onset comparable to other agents in the same class, such as granisetron or dolasetron. Unlike dopamine antagonists, it has a lower incidence of extrapyramidal side effects. Its efficacy in chemotherapy‑induced nausea is well‑established, making it a preferred choice when a fast, reliable IV antiemetic is needed.
What are the storage and handling requirements for Ondansetron Kabi?+
Ondansetron Kabi must be stored at 2‑8 °C in a refrigerator, protected from light. It should not be frozen or shaken. Use aseptic technique when preparing the solution for intravenous administration, and ensure the product remains within the recommended temperature range throughout handling and transport.
How is Ondansetron Kabi administered?+
Ondansetron Kabi is given as an intravenous injection. The solution is typically diluted in a compatible IV fluid and infused over a few minutes, as directed by the prescriber. Administration follows standard aseptic procedures, and the infusion rate may be adjusted based on the clinical situation and patient response.
What are the most serious risks associated with Ondansetron Kabi?+
The most serious risks include QT interval prolongation, which can lead to potentially life‑threatening cardiac arrhythmias, severe hypersensitivity reactions such as anaphylaxis, and serotonin syndrome when combined with other serotonergic medications. Patients with known cardiac conduction disorders or those taking other QT‑prolonging drugs require careful monitoring.
Who should not use Ondansetron Kabi?+
Ondansetron Kabi should be avoided in patients with a known hypersensitivity to ondansetron or any other 5‑HT3 antagonists, individuals with congenital long QT syndrome, and those currently taking contraindicated QT‑prolonging medications unless the therapeutic benefit outweighs the risk. Clinicians must assess each patient’s medical history before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ondansetron Hydrochloride Dihydrate
Route
Intravenous Use
Manufacturer
Fresenius Kabi Hellas Single Member S.A.
Origin
EU

Related products

Cellondan

Cellondan

Ondansetron Hydrochloride Dihydrate

Stadapharm Gmbh
EU
Cellondan

Cellondan

Ondansetron Hydrochloride Dihydrate

Stadapharm Gmbh
EU
Emeset

Emeset

Ondansetron Hydrochloride Dihydrate

Amring Farma Srl
EU
Emetron

Emetron

Ondansetron Hydrochloride Dihydrate

Gedeon Richter Plc.
EU